Skip to content

Surviving Opioid Overdose With Naloxone Education and Resuscitation Trial (SOONER)

Surviving Opioid Overdose With Naloxone Education and Resuscitation Trial (SOONER): Randomized Trial and Embedded Qualitative Study to Compare the Effectiveness of point-of Care Overdose Education and Naloxone Distribution Versus Referral to an Existing Community Program in the Management of Simulated Opioid-associated Resuscitative Emergencies.

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04740099
Acronym
SOONER
Enrollment
0
Registered
2021-02-05
Start date
2021-12-31
Completion date
2023-03-31
Last updated
2022-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Education, Opioid Overdose, Opioid-Related Disorders, Opioid Use, Opioid Withdrawal, Resusitation

Brief summary

Among people at risk of opioid overdose and receiving care in an academic emergency department, family practice, opioid substitution clinic or general inpatient units, does brief opioid overdose resuscitation training and naloxone distribution reduce resuscitation failures in a simulated overdose even, in comparison with standard-of-care referral to a local OEND program, within 14 days post-intervention? Can an integrated participant recruitment and retention strategy recruit approximately 28 eligible participants within 4 weeks and maintain less than 50% attrition rates in the context of a randomized trial on point-of-care OEND and simulated overdose resuscitation performance in family practice, emergency department, and addictions settings?

Interventions

OTHERSOONER Video & Kit

A brief animated video including basic instructions for opioid overdose response accompanied by a Naloxone kit with an info graphic.

OTHERStandard of Care

A handout including a map and list of locations offering this service.

Sponsors

Toronto Public Health
CollaboratorOTHER_GOV
Ontario College of Art and Design (OCAD)
CollaboratorUNKNOWN
University of Toronto
CollaboratorOTHER
Unity Health Toronto
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE (Investigator, Outcomes Assessor)

Intervention model description

Pragmatic, multi-site, 2-armed, parallel-group, best available care controlled, analyst- and outcome assessor-blinded, superiority trial with embedded qualitative study.

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. adults ≥16 years of age, and 2. Eligible for overdose education according to criteria adapted from the 2015 American Heart Association Guidelines by meeting any one or more of the following criteria: 1. has a history of taking opioids at recognized 'high doses' (whether by prescription or otherwise, defined as \>100mg morphine equivalent per day); 2. has required emergency care for opioid overdose previously; 3. is enrolled in opioid agonist treatment programs, including methadone or buprenorphine maintenance programs, or stopped an opioid agonist treatment program in the last 6 months; 4. uses non-medical opioids, injects opioids, or acquires opioids from sources other than a pharmacy or healthcare setting; 5. has a history of non-medical opioid use who are being released from prison; 6. is receiving prescription opioid therapy with risk factors for adverse effects, including i. relevant comorbidities, ii. co-prescriptions of benzodiazepines or other sedatives, iii. concomitant ongoing alcohol use, iv. use of prescription opioids not as prescribed. 7. is likely to witness an opioid overdose, defined as anyone who lives with or is in frequent contact with others who use opioids, or who has previously witnessed an opioid overdose.

Exclusion criteria

1. plan to move away from Toronto during the study period 2. have no mode of contact or follow-up, 3. have a community do not resuscitate order, 4. have a terminal illness, end-of-life care, or illness likely to result in death within the study period, 5. are an active or previously practicing healthcare professional or professional first responder (e.g.: firefighter, police officer, lifeguard, industrial first responder), or 6. have insufficient English language skills to participate in the study.

Design outcomes

Primary

MeasureTime frameDescription
Satisfactory basic life support performance4-14 days after enrolmentSatisfactory basic life support performance on a standardized high fidelity overdose simulation, as assessed by the consensus of two trained clinicians.

Secondary

MeasureTime frameDescription
Performance on basic resuscitation skill: Recognize the Emergency4-14 days after enrolmentSkill performance will be rated as either satisfactory or unsatisfactory by two trained clinicians. Inter-rater reliability of the assessors for each of the eight secondary outcome skills will be calculated.
Performance on basic resuscitation skill: Position the Victim4-14 days after enrolmentSkill performance will be rated as either satisfactory or unsatisfactory by two trained clinicians. Inter-rater reliability of the assessors for each of the eight secondary outcome skills will be calculated.
Performance on basic resuscitation skill: Activate emergency medical services4-14 days after enrolmentSkill performance will be rated as either satisfactory or unsatisfactory by two trained clinicians. Inter-rater reliability of the assessors for each of the eight secondary outcome skills will be calculated.
Performance on basic resuscitation skill: Administer Naloxone4-14 days after enrolmentSkill performance on device preparation and correct administration will be rated as either satisfactory or unsatisfactory by two trained clinicians. Inter-rater reliability of the assessors for each of the eight secondary outcome skills will be calculated.
Performance on basic resuscitation skill: chest compressions4-14 days after enrolmentSkill performance (rate and depth of chest compressions) will be rated as either satisfactory or unsatisfactory by two trained clinicians. Inter-rater reliability of the assessors for each of the eight secondary outcome skills will be calculated.
Performance on basic resuscitation skill: continue compressions until end of simulation4-14 days after enrolmentSkill performance will be rated as either satisfactory or unsatisfactory by two trained clinicians. Inter-rater reliability of the assessors for each of the eight secondary outcome skills will be calculated.
Performance on basic resuscitation skill: order of operations4-14 days after enrolmentSkill performance will be rated as either satisfactory or unsatisfactory by two trained clinicians. Inter-rater reliability of the assessors for each of the eight secondary outcome skills will be calculated.
Performance on basic resuscitation skill: Hand placement4-14 days after enrolmentSkill performance will be rated as either satisfactory or unsatisfactory by two trained clinicians. Inter-rater reliability of the assessors for each of the eight secondary outcome skills will be calculated.

Other

MeasureTime frameDescription
Standardized assessor-implemented survey and interview responses to measure overdose-related knowledge and behaviours4-14 days after enrolmentThe questionnaires were developed for the Toronto Public Health OEND program evaluation using data points from other overdose education and naloxone distribution programs and from the validated Opioid Overdose Knowledge and Attitudes Scales (OOKS and OOAS). We also included relevant questions from a national survey of injection drug users (ITRACK, Health Canada) and the CAMH Monitor conducted by the Centre for Addiction and Mental Health (CAMH). The questionnaire items include: 1. Demographics: age, gender, ethnicity, housing status, and neighbourhood 2. Prescription medications 3. Opioid and non-opioid drug use in past 4 weeks: drug, amount, route, frequency 4. Drug use setting: where and with whom opioids were used 5. Periods of abstinence 6. Use of prevention strategies, and speaking to others about overdose or overdose response 7. Knowledge of overdose and naloxone use 8. Status of naloxone kit 9. Willingness and confidence to respond to overdose

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026